Re-Focused Kiadis Preps Trials With Natural Killer Cells

Revamped Biotech Trialling NK-cells In AML and HSCT

 
• By Sten Stovall
  
Cancer_Cells
Kiadis is researching NK cells for their therapeutic potential • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D